腎臓学および泌尿器学デバイス市場規模、シェア、動向分析レポート:製品別(尿管カテーテル、PCNカテーテル、泌尿器学ガイドワイヤー)、用途別、最終用途別、地域別、セグメント別予測、2023年~2030年Nephrology And Urology Devices Market Size, Share & Trends Analysis Report By Product (Ureteral Catheters, PCN Catheters, Urology Guidewires), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030 腎臓・泌尿器デバイス市場の成長と動向 Grand View Research, Inc.の最新レポートによると、世界の腎臓学および泌尿器学機器市場規模は2030年までに94.4億米ドルに達すると予測され、2023年から2030年までのCA... もっと見る
1~3営業日
サマリー腎臓・泌尿器デバイス市場の成長と動向Grand View Research, Inc.の最新レポートによると、世界の腎臓学および泌尿器学機器市場規模は2030年までに94.4億米ドルに達すると予測され、2023年から2030年までのCAGRは6.9%で拡大する。不健康なライフスタイル、喫煙や飲酒の増加、不規則な食生活は、腎臓・泌尿器疾患をもたらす要因の一部である。このため、予測期間中に腎臓・泌尿器科用機器の需要が増加すると予想される。慢性腎臓病患者の増加は、業界の成長を促進すると予想される。全米腎臓財団2019によると、慢性腎臓病(CKD)を患う人は世界中に200万人以上いると推定され、毎年数百万人がこの疾患で死亡している。この数は年間5~7%の割合で増え続けている。 COVID-19患者を治療するために医療現場の限られたスペースを確保するため、泌尿器科の選択的手術の大半が延期されたためである。例えば、最近発表された欧州泌尿器科学会の調査によると、COVID-19患者を入院させるために泌尿器科のベッド稼働率が48.6%減少し、54.2%の病院で臨床活動が停止した。しかし、COVID-19患者はその後、過活動膀胱(OAB)の新たな症状や悪化した症状を示しており、近い将来、業界の成長に有利な環境を作り出すことが期待できるかもしれない。 さらに、低侵襲手技の採用拡大が市場成長を促進すると予想される。コンドームカテーテル、ドップラー超音波ビデオ尿流動態、膀胱内前立腺突出症、陰茎カフなど、痛みを伴うカテーテル留置を回避するのに役立つ非侵襲的手技が数多く市場に導入されている。このような要因により、腎臓・泌尿器科用器具の市場販売が増加している。 腎臓学および泌尿器学機器市場レポートハイライト - 製品別では、泌尿器科および腎臓に関連する疾患の世界的な有病率の高さ、および主要企業による技術的に高度な製品の発売により、2022年の売上高シェアは27.94%を超え、その他のセグメントが市場を支配した。 - PCNカテーテルは、尿閉塞時の一時的な転換に使用されるため、さまざまな腎臓関連疾患への応用が増加していることから、2023年から2030年にかけて最も高いCAGR 7.8%で拡大すると予想される。 - 2022年の売上高シェアは32.9%超で北米が市場を独占した。有力企業の存在、高度な医療インフラ、医療制度における公的資金の多寡などが、この地域の市場成長の要因となっている。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. Application 1.1.3. End-user 1.1.4. Regional scope 1.1.5. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.4. Information or Data Analysis 1.5. Market Formulation & Validation 1.6. Model Details 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Application outlook 2.2.3. End-use outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Nephrology & Urology Devices Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Market Dynamics 3.3.1. Market driver analysis 3.3.2. Market restraint analysis 3.4. Nephrology & Urology Devices Market Analysis Tools 3.4.1. Industry Analysis - Porter’s Five Forces 3.4.1.1. Supplier power 3.4.1.2. Buyer power 3.4.1.3. Substitution threat 3.4.1.4. Threat of new entrant 3.4.1.5. Competitive rivalry 3.4.2. PESTEL Analysis 3.4.2.1. Political landscape 3.4.2.2. Technological landscape 3.4.2.3. Economic landscape Chapter 4. Nephrology & Urology Devices Market: Product Estimates & Trend Analysis 4.1. Nephrology and Urology Devices Market: Key Takeaways 4.2. Nephrology and Urology Devices Market: Product Movement & Market Share Analysis, 2022 & 2030 4.3. Ureteral Catheters 4.3.1. Ureteral catheters market estimates and forecasts, 2018 to 2030 (USD Million) 4.4. PCN Catheters 4.4.1. PCN catheters market estimates and forecasts, 2018 to 2030 (USD Million) 4.5. Urinary Stents 4.5.1. Urinary stents market estimates and forecasts, 2018 to 2030 (USD Million) 4.6. Stone Basket 4.6.1. Stone basket market estimates and forecasts, 2018 to 2030 (USD Million) 4.7. Urology Guidewires 4.7.1. Urology guidewires market estimates and forecasts, 2018 to 2030 (USD Million) 4.8. Renal Dilators 4.8.1. Renal dilators market estimates and forecasts, 2018 to 2030 (USD Million) 4.9. Others 4.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 5. Nephrology & Urology Devices Market: Application Estimates & Trend Analysis 5.1. Nephrology and Urology Devices Market: Key Takeaways 5.2. Nephrology and Urology Devices Market: Application Movement & Market Share Analysis, 2022 & 2030 5.3. Urolithiasis 5.3.1. Urolithiasis market estimates and forecasts, 2018 to 2030 (USD Million) 5.4. Urological Cancer & BPH 5.4.1. Urological cancer & BPH market estimates and forecasts, 2018 to 2030 (USD Million) 5.5. Bladder Disorders 5.5.1. Bladder Disorders market estimates and forecasts, 2018 to 2030 (USD Million) 5.6. Kidney Diseases 5.6.1. Kidney Diseases market estimates and forecasts, 2018 to 2030 (USD Million) 5.7. Others 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 6. Nephrology & Urology Devices Market: End-use Estimates & Trend Analysis 6.1. Nephrology and Urology Devices Market: Key Takeaways 6.2. Nephrology and Urology Devices Market: End-use Movement & Market Share Analysis, 2022 & 2030 6.3. Hospitals 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million) 6.4. Clinics 6.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million) 6.5. Ambulatory Surgical Centers 6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million) 6.6. Others 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 7. Nephrology & Urology Devices Market: Regional Estimates & Trend Analysis 7.1. Regional Outlook 7.2. Nephrology and Urology Devices Market by Region: Key Takeaways 7.3. North America 7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 7.3.2. U.S. 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.3.3. Canada 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4. Europe 7.4.1. UK 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.2. Germany 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.3. France 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.4. Italy 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.5. Spain 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.6. Sweden 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.7. Norway 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.8. Denmark 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5. Asia Pacific 7.5.1. China 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.2. Japan 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Volume, Thousand) 7.5.3. India 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.4. Australia 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.5. Thailand 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.6. South Korea 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6. Latin America 7.6.1. Brazil 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6.2. Mexico 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6.3. Argentina 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7. MEA 7.7.1. Saudi Arabia 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.2. South Africa 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.3. UAE 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.4. Kuwait 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Market Participant Categorization 8.2.1. Medtronic 8.2.1.1. Company overview 8.2.1.2. Financial performance 8.2.1.3. Product benchmarking 8.2.1.4. Strategic initiatives 8.2.2. Coloplast 8.2.2.1. Company overview 8.2.2.2. Financial performance 8.2.2.3. Product benchmarking 8.2.2.4. Strategic initiatives 8.2.3. Boston Scientific Corporation 8.2.3.1. Company overview 8.2.3.2. Financial performance 8.2.3.3. Product benchmarking 8.2.3.4. Strategic initiatives 8.2.4. Convatec Group plc 8.2.4.1. Company overview 8.2.4.2. Financial performance 8.2.4.3. Product benchmarking 8.2.4.4. Strategic initiatives 8.2.5. B. Braun SE 8.2.5.1. Company overview 8.2.5.2. Financial performance 8.2.5.3. Product benchmarking 8.2.5.4. Strategic initiatives 8.2.6. Hollister Incorporated 8.2.6.1. Company overview 8.2.6.2. Financial performance 8.2.6.3. Product benchmarking 8.2.6.4. Strategic initiatives 8.2.7. Teleflex Inc. 8.2.7.1. Company overview 8.2.7.2. Financial performance 8.2.7.3. Product benchmarking 8.2.7.4. Strategic initiatives 8.2.8. Baxter 8.2.8.1. Company overview 8.2.8.2. Financial performance 8.2.8.3. Product benchmarking 8.2.8.4. Strategic initiatives 8.2.9. Fresenius Medical Care AG & Co. 8.2.9.1. Company overview 8.2.9.2. Financial performance 8.2.9.3. Product benchmarking 8.2.9.4. Strategic initiatives 8.2.10. Asahi Kasei Corporation 8.2.10.1. Company overview 8.2.10.2. Financial performance 8.2.10.3. Product benchmarking 8.2.10.4. Strategic initiatives 8.2.11. Cook Group 8.2.11.1. Company overview 8.2.11.2. Financial performance 8.2.11.3. Product benchmarking 8.2.11.4. Strategic initiatives 8.2.12. C. R. Bard Inc. 8.2.12.1. Company overview 8.2.12.2. Financial performance 8.2.12.3. Product benchmarking 8.2.12.4. Strategic initiatives 8.2.13. Terumo Corporation 8.2.13.1. Company overview 8.2.13.2. Financial performance 8.2.13.3. Product benchmarking 8.2.13.4. Strategic initiatives 8.2.14. NxStage Medical, Inc. 8.2.14.1. Company overview 8.2.14.2. Financial performance 8.2.14.3. Product benchmarking 8.2.14.4. Strategic initiatives 8.2.15. Nipro Medical Corporation 8.2.15.1. Company overview 8.2.15.2. Financial performance 8.2.15.3. Product benchmarking 8.2.15.4. Strategic initiatives
SummaryNephrology And Urology Devices Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. Application 1.1.3. End-user 1.1.4. Regional scope 1.1.5. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.4. Information or Data Analysis 1.5. Market Formulation & Validation 1.6. Model Details 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Application outlook 2.2.3. End-use outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Nephrology & Urology Devices Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Market Dynamics 3.3.1. Market driver analysis 3.3.2. Market restraint analysis 3.4. Nephrology & Urology Devices Market Analysis Tools 3.4.1. Industry Analysis - Porter’s Five Forces 3.4.1.1. Supplier power 3.4.1.2. Buyer power 3.4.1.3. Substitution threat 3.4.1.4. Threat of new entrant 3.4.1.5. Competitive rivalry 3.4.2. PESTEL Analysis 3.4.2.1. Political landscape 3.4.2.2. Technological landscape 3.4.2.3. Economic landscape Chapter 4. Nephrology & Urology Devices Market: Product Estimates & Trend Analysis 4.1. Nephrology and Urology Devices Market: Key Takeaways 4.2. Nephrology and Urology Devices Market: Product Movement & Market Share Analysis, 2022 & 2030 4.3. Ureteral Catheters 4.3.1. Ureteral catheters market estimates and forecasts, 2018 to 2030 (USD Million) 4.4. PCN Catheters 4.4.1. PCN catheters market estimates and forecasts, 2018 to 2030 (USD Million) 4.5. Urinary Stents 4.5.1. Urinary stents market estimates and forecasts, 2018 to 2030 (USD Million) 4.6. Stone Basket 4.6.1. Stone basket market estimates and forecasts, 2018 to 2030 (USD Million) 4.7. Urology Guidewires 4.7.1. Urology guidewires market estimates and forecasts, 2018 to 2030 (USD Million) 4.8. Renal Dilators 4.8.1. Renal dilators market estimates and forecasts, 2018 to 2030 (USD Million) 4.9. Others 4.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 5. Nephrology & Urology Devices Market: Application Estimates & Trend Analysis 5.1. Nephrology and Urology Devices Market: Key Takeaways 5.2. Nephrology and Urology Devices Market: Application Movement & Market Share Analysis, 2022 & 2030 5.3. Urolithiasis 5.3.1. Urolithiasis market estimates and forecasts, 2018 to 2030 (USD Million) 5.4. Urological Cancer & BPH 5.4.1. Urological cancer & BPH market estimates and forecasts, 2018 to 2030 (USD Million) 5.5. Bladder Disorders 5.5.1. Bladder Disorders market estimates and forecasts, 2018 to 2030 (USD Million) 5.6. Kidney Diseases 5.6.1. Kidney Diseases market estimates and forecasts, 2018 to 2030 (USD Million) 5.7. Others 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 6. Nephrology & Urology Devices Market: End-use Estimates & Trend Analysis 6.1. Nephrology and Urology Devices Market: Key Takeaways 6.2. Nephrology and Urology Devices Market: End-use Movement & Market Share Analysis, 2022 & 2030 6.3. Hospitals 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million) 6.4. Clinics 6.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million) 6.5. Ambulatory Surgical Centers 6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million) 6.6. Others 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 7. Nephrology & Urology Devices Market: Regional Estimates & Trend Analysis 7.1. Regional Outlook 7.2. Nephrology and Urology Devices Market by Region: Key Takeaways 7.3. North America 7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 7.3.2. U.S. 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.3.3. Canada 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4. Europe 7.4.1. UK 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.2. Germany 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.3. France 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.4. Italy 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.5. Spain 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.6. Sweden 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.7. Norway 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.8. Denmark 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5. Asia Pacific 7.5.1. China 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.2. Japan 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Volume, Thousand) 7.5.3. India 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.4. Australia 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.5. Thailand 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.6. South Korea 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6. Latin America 7.6.1. Brazil 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6.2. Mexico 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6.3. Argentina 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7. MEA 7.7.1. Saudi Arabia 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.2. South Africa 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.3. UAE 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.4. Kuwait 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Market Participant Categorization 8.2.1. Medtronic 8.2.1.1. Company overview 8.2.1.2. Financial performance 8.2.1.3. Product benchmarking 8.2.1.4. Strategic initiatives 8.2.2. Coloplast 8.2.2.1. Company overview 8.2.2.2. Financial performance 8.2.2.3. Product benchmarking 8.2.2.4. Strategic initiatives 8.2.3. Boston Scientific Corporation 8.2.3.1. Company overview 8.2.3.2. Financial performance 8.2.3.3. Product benchmarking 8.2.3.4. Strategic initiatives 8.2.4. Convatec Group plc 8.2.4.1. Company overview 8.2.4.2. Financial performance 8.2.4.3. Product benchmarking 8.2.4.4. Strategic initiatives 8.2.5. B. Braun SE 8.2.5.1. Company overview 8.2.5.2. Financial performance 8.2.5.3. Product benchmarking 8.2.5.4. Strategic initiatives 8.2.6. Hollister Incorporated 8.2.6.1. Company overview 8.2.6.2. Financial performance 8.2.6.3. Product benchmarking 8.2.6.4. Strategic initiatives 8.2.7. Teleflex Inc. 8.2.7.1. Company overview 8.2.7.2. Financial performance 8.2.7.3. Product benchmarking 8.2.7.4. Strategic initiatives 8.2.8. Baxter 8.2.8.1. Company overview 8.2.8.2. Financial performance 8.2.8.3. Product benchmarking 8.2.8.4. Strategic initiatives 8.2.9. Fresenius Medical Care AG & Co. 8.2.9.1. Company overview 8.2.9.2. Financial performance 8.2.9.3. Product benchmarking 8.2.9.4. Strategic initiatives 8.2.10. Asahi Kasei Corporation 8.2.10.1. Company overview 8.2.10.2. Financial performance 8.2.10.3. Product benchmarking 8.2.10.4. Strategic initiatives 8.2.11. Cook Group 8.2.11.1. Company overview 8.2.11.2. Financial performance 8.2.11.3. Product benchmarking 8.2.11.4. Strategic initiatives 8.2.12. C. R. Bard Inc. 8.2.12.1. Company overview 8.2.12.2. Financial performance 8.2.12.3. Product benchmarking 8.2.12.4. Strategic initiatives 8.2.13. Terumo Corporation 8.2.13.1. Company overview 8.2.13.2. Financial performance 8.2.13.3. Product benchmarking 8.2.13.4. Strategic initiatives 8.2.14. NxStage Medical, Inc. 8.2.14.1. Company overview 8.2.14.2. Financial performance 8.2.14.3. Product benchmarking 8.2.14.4. Strategic initiatives 8.2.15. Nipro Medical Corporation 8.2.15.1. Company overview 8.2.15.2. Financial performance 8.2.15.3. Product benchmarking 8.2.15.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Grand View Research社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD(devices)の最新刊レポートよくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |